Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Takung Art Co., LtdFinancial_Report.xls

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q/A

Amendment No. 1


 

(Mark One)

X

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2014

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                     to

 

Commission file number 333-176329

 

CARDIGANT MEDICAL, INC.

(Exact name of Registrant as Specified in Its Charter)

 

DELAWARE

 

26-4731758

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

 

 

1500 ROSECRANS AVENUE, ST 500, MANHATTAN BEACH, CALIFORNIA

 

90266

(Address of principal executive offices)

 

(Zip Code)

 

Registrants telephone number, including area code: (310) 421-8654

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes   X  No  

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes   X  No  

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act (Check one).

 

Large Accelerated Filer   

Accelerated Filer

Non-Accelerated Filer 

Smaller reporting company X  

 

 

(Do not check if a smaller reporting company)

 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes   o    No  X

As of August 01, 2014, there were 23,330,662 shares of the registrants common stock outstanding.





1


The Registrant is filing this Amendment No. 1 to the Registrants Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2014 (Form 10-Q) solely to include the required XBRL files. While the XBRL files were included in the original filing, they were excluded from the Edgar system due to an internal reference to the 2012 US GAAP taxonomy. The 2013 taxonomy is now required.


Except for the items mentioned above, this Amendment No. 1 does not amend the Registrants previously filed Form 10-Q.




2


SIGNATURES 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

CARDIGANT MEDICAL, INC.

 


By: /s/ Jerett A. Creed

Dated: August 25, 2014

 

Jerett A. Creed

 

 

Chief Executive Officer






By: /s/ Jerett A. Creed

Dated: August 25, 2014


Jerett A. Creed



Chief Financial Officer (Principal Financial Officer and  Principal Accounting Officer)

 







3